| INTRODUC TI ON
Intrauterine growth restriction is a serious complication of pregnancy that is a major predictor of neonatal mortality and morbidities. 1 Decreased weight for gestational age at birth, which comprises normal as well as pathologic variation, is associated with consequences that last into childhood and even adult life. 2, 3 Known contributors to pathologic fetal growth restriction include congenital anomalies and extreme maternal dietary restriction. However, numerous other factors can alter implantation and development of the placenta, hormone transfer to the fetus, and supply and demand of nutrients that can adversely affect growth.
Maternal infection with diseases like malaria, which is characterized by activation of inflammation and oxidative stress pathways, is strongly associated with fetal growth restriction. 4 However, the impact of elevated but subclinical levels of inflammation and oxidative stress is less well known. Data from animal and cellular models suggest that inflammation and oxidative stress early in pregnancy can interfere with normal placentation, namely by inducing apoptosis of the syncytiotrophoblast and impairing invasion of the spiral arterioles. 5 Studies in humans, however, are limited by the availability of biomarker measurements from single time points during gestation or the use of birthweight alone as a proxy for growth. [6] [7] [8] [9] [10] [11] [12] [13] [14] In this study, we sought to address whether maternal inflammation and oxidative stress biomarker concentrations measured longitudinally across pregnancy were associated with repeated ultrasound as well as delivery measures of fetal growth. Additionally, we examined whether associations between biomarkers and growth differed depending on when they were measured during pregnancy, what parameter was used to assess growth (eg, weight or head circumference), and sex of the fetus.
| MATERIAL S AND ME THODS

| Study population
LIFECODES is an ongoing prospective birth cohort conducted at
Brigham and Women's Hospital (BWH) in Boston, MA. Women are recruited early in gestation (prior to 15 weeks) and provide repeated biological specimens at up to four study visits. Recruitment has been ongoing since 2006. For the present analysis, we included women who were part of a nested case-control study of preterm birth that was originally designed to assess the relationship between phthalate exposure and prematurity in pregnancy, and to investigate longitudinal biomarkers of oxidative stress and inflammation that were hypothesized to mediate that assocation. 15, 16 This study comprised all cases of preterm birth (defined as delivery prior to 37-week gestation; n = 130) as well as 3:1 randomly selected controls (n = 352) who delivered between 2006 and 2008. 17 The present secondary analysis leveraged this existing data, which, to our knowledge, are not available in any other epidemiologic study, to investigate the relationship between inflammation and oxidative stress biomarkers in pregnancy and fetal growth. Unadjusted analysis within the casecontrol population would bias effect estimates, as biomarkers are elevated in cases of preterm birth and babies born preterm are smaller and in many cases growth-restricted. Thus, we applied inverse probability weights to all analyses to account for the case-control study design. 18 This approach effectively downweights associations observed between biomarkers and growth parameters in cases of preterm to the proportion at which they would be observed in the base LIFECODES population (ie, 12%) and ensures that the results from this analysis are generalizable.
| Inflammation and oxidative stress biomarkers
Urine and plasma samples were collected at enrollment (median 10 weeks), and at three subsequent visits (median 18, 26, and 35 weeks). In urine, we measured two biomarkers of oxidative stress in each sample: total 8-isoprostane, an indicator of lipid peroxidation; and 8-hydroxydeoxyguanosine (8-OHdG), an indicator of oxidative DNA damage. For 8-isoprostane, samples underwent an affinity purification step. Concentrations of both analytes were measured using enzyme immunoassay. All analyses were performed at Cayman
Chemical (Ann Arbor, MI, USA) using methods described in detail elsewhere. 15 To adjust for urine dilution, specific gravity was meas-
Distributions of all inflammation and oxidative stress markers were right-skewed and natural-log transformed for statistical analyses.
| Measures of fetal growth
Gestational age for the LIFECODES study is assessed by last menstrual period with verification by crown-rump length (median 10 weeks) ultrasound. 19 In addition to the gestational dating ultra- 
| Model selection and statistical analysis
All analyses conducted in SAS version 9.4 (Cary, NC, USA).
Demographic characteristics of the study population were tabu- 
| RE SULTS
The overall study population (N = 482) was primarily White and well-educated (Table 1) . Slightly more than half of the babies were female (55%). Differences in birthweight z-scores by demographic characteristics in this study population have been previously reported. 23 As expected, birthweight z-scores were lower in mothers who self-identified as Black, had lower BMI, had public health insurance providers, and who were nulliparous compared to reference. Unexpectedly, birthweight z-scores were also slightly lower in male compared to female fetuses in this study population. Oxidative stress and inflammation biomarkers showed moderate to high stability in repeated measures across pregnancy, and tended to be higher in mothers who were Black, had higher BMI, and who had lower socioeconomic status. 15, 16 Adjusted LMMs showed that each inflammation biomarker was inversely associated with fetal growth, as indicated by repeated z-scores of head circumference, abdominal circumference, femur length, and weight; however, few associations reached statistical significance ( Table 2 ). The most consistent associations, and the effect estimates that were greatest in magnitude, were between CRP and growth measurements. For example, an interquartile range (IQR) increase in CRP was associated with a 0.12 standard deviation decrease in weight z-score (95% confidence interval, CI = −0.21, −0.02), which corresponds to a decrease in 50 grams at 40 weeks gestation (based on mean birthweight at week 40 in the BWH population). 23 Additionally, IL-1β was associated with a 0.08 standard deviation decrease in head circumference z-score (95% CI=−0.17, 0.00).
To identify windows of vulnerability during pregnancy, we next examined models of inflammation biomarkers by visit in relation to repeated measures of weight (ie, estimated fetal weight z-scores at visits 3 and 4 and birthweight z-score at delivery). For CRP, we observed that associations between levels measured at visits 1 and 2 in pregnancy were not associated with weight; however, higher levels of CRP measured at visits 3 and particularly at 4 were associated with lower weight (Figure 1 ; effect estimates presented in Table S1 ).
This suggests later pregnancy as a potentially vulnerable window when higher levels of inflammation could have a greater influence on fetal growth. Patterns were similar but less precise for IL-1β, and associations for other cytokines were null (Table S1 ).
We also investigated whether inflammation marker associations with fetal growth differed by sex of the fetus by creating stratified models. Associations between CRP and weight were similar in males and females (Figure 2 ; effect estimates presented in Table S2 ), but associations between IL-1β and weight were inverse for males and indicated by each anthropometric measurement; however, the effect estimates for associations with head circumference and femur length were greatest in magnitude (ie, most negative; Table 3 ). When we examined associations by study visit to investigate windows of vulnerability, 8-isoprostane levels measured at visit 3 were inversely associated with weight and 8-OHdG levels at visit 1 were positively associated with weight ( Figure 1 ; effect estimates in Table S2 ).
An IQR increase in 8-
In models stratified by sex, associations were mostly null Figure 2 ; effect estimates presented in Table S2 ). However, we observed that the inverse association between 8-OHdG and weight was stronger in females compared to males (P for interaction=0.09).
| D ISCUSS I ON
Inflammation has long been suspected to play an important role in growth restriction and preeclampsia, although support is more consistent for the latter. 25 Animal evidence also strongly supports a causative relationship between inflammation and reduced fetal growth. The largest study in humans to address this research question was within the Generation R birth cohort, in which CRP levels were measured in the first trimester of pregnancy. 7 Increased levels were associated with lower estimated fetal weight, measured by ultrasound in the third trimester, and also with lower birthweight. Few studies have examined cytokines in relation to birthweight or fetal growth, 8, 10 and to our knowledge none has done so with repeated biomarkers or ultrasound measurements. Our largely null findings for inflammatory cytokines suggest these markers may not be useful in the study of fetal growth. This may be due to poor correlation between plasma cytokines and inflammation in the compartment of interest (eg, placenta or fetus). Additional work to examine this question in more detail is warranted.
Oxidative stress is an imbalance between reactive oxygen species and antioxidant capacity that may result from or cause inflammation. While an elevation of oxidative stress in early pregnancy relative to pre-pregnancy is normal, levels that are too high could interfere with normal placentation. Few studies in humans have investigated associations between prenatal oxidative stress biomarkers and fetal growth. Studies measuring 8-OHdG levels in urine from early 11, 12 as well as late 9, 14 pregnancy have demonstrated associations with decreased birthweight or increased risk of small for gestational age. Our findings are consistent with these data, as we observed associations between repeated measures of 8-OHdG over pregnancy and decreased head circumference and femur length zscores. Interestingly, the association with weight was strongest in girls in our stratified analysis by fetal sex, which was also observed by Lindstrom et al.
11
Levels of 8-isoprostane in amniotic fluid collected during pregnancy have been strongly associated with fetal growth restriction. 28 However, the Lindstrom study, which examined urinary 8-isoprostane concentrations at both 14-and 30-week gestation, found no association with birthweight or other metrics at delivery.
In fact, they observed that elevated levels early in pregnancy were associated with increased weight. We found that 8-isoprostane was inversely associated with repeated measures of head circumference and femur length, and that levels at ~26 weeks gestation were associated with decreased weight. This may suggest that oxidative stress levels in pregnancy have a stronger influence on some anthropometric parameters (eg, head size) compared to others.
Our study of inflammation and oxidative stress markers in relation to fetal growth was limited in part by our study population.
This was a secondary analysis using existing data from a nested case-control study of preterm birth. This population was chosen for this analysis because of the availability of the rich set of biomarkers of inflammation and oxidative stress. However, it was not designed specifically to investigate the associations between these biomarkers and fetal growth. Because of inverse probability weights applied to all analyses, the results are adjusted for the case-control design and the findings do not overly represent associations that are unique to cases of preterm birth. The primary limitations of using this study population are due to the fact that the ultrasound data utilized in the present analysis was collected clinically and not for research purposes. This could limit the quality of the data collected. Additionally, because scans later in pregnancy are more likely to be performed among women who are suspected to have pregnancy complications, our findings may be characteristic of events occurring in higher risk pregnancy. Also for this reason, our sample size was limited for analyses examining ultrasound measurements only (head and abdominal circumference and femur length). Nevertheless, these data provide
additional power beyond what we could muster using birth measurements alone. Furthermore, they provide the ability to examine individual anthropometric parameters like head circumference and femur length, which are rarely captured in these types of studies.
Because of the limited availability of repeat ultrasound measurements in pregnancy, we were unable to capture associations with rates of growth during gestation, which may be particularly important. In our other studies of inflammation and oxidative stress measures in relation to preterm birth and preeclampsia we were able to separate cases based on presentations that may have more homogeneous etiologies (including spontaneous vs placentally mediated for preterm birth and early vs late onset for preeclampsia).
Distinguishing pathologic from normal fetal growth is a more difficult challenge.
TA B L E 3 Adjusted a change in repeated b z-score measures of fetal growth in association with an interquartile range difference in oxidative stress biomarker from repeated-measures models This study benefited from the availability of four measurements of a panel of both inflammation and oxidative stress measures during pregnancy, which allowed us to examine windows during gestation when these levels may be particularly influential. We also were able to utilize ultrasound measurements of fetal growth, which gave us greater power in repeated-measures models and also allowed us to identify associations with anthropometric parameters that had not been examined in relation to these markers in the past.
In conclusion, we observed inverse associations between CRP and fetal weight and between the oxidative stress markers 8-OHdG and 8-isoprostane and head circumference and femur length. Effect estimates for CRP were strongest (ie, most negative) with levels measured later in pregnancy, and the same was true for 8-isoprostane.
This represents the first study to our knowledge to examine associations between inflammation and oxidative stress biomarkers measured at multiple time points within the same participants in relation to fetal growth. These findings inform not only the understanding of biological changes in pregnancy that are related to perturbations in fetal growth, but also could help to explain why perturbations in fetal growth are linked to consequences in childhood and later in life.
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